Bristow L J, Landon L, Saywell K L, Tricklebank M D
Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Harlow, Essex, UK.
Psychopharmacology (Berl). 1995 Mar;118(2):230-2. doi: 10.1007/BF02245847.
Previous studies have demonstrated that the glycine/NMDA receptor antagonist, L-701,324 (7-chloro-4-hydroxy-3(3-phenoxy)phenyl-2(H)quinolone) blocks the activation of mesolimbic dopamine systems induced following psychostimulant administration in the rat (Bristow et al. 1994). In the present study, pretreatment with L-701,324 also reversed the deficit in prepulse inhibition (PPI) observed in rats reared in social isolation after weaning. Given that PPI is also attenuated in schizophrenic patients and that isolation rearing induces both neurochemical and behavioural abnormalities suggestive of a physiologically induced state of dopaminergic hyperactivity, these results suggest that blockade of the glycine/NMDA receptor may offer a new strategy for the development of novel antipsychotic agents.
先前的研究表明,甘氨酸/N-甲基-D-天冬氨酸受体拮抗剂L-701,324(7-氯-4-羟基-3(3-苯氧基)苯基-2(H)-喹诺酮)可阻断大鼠在给予精神兴奋剂后诱导的中脑边缘多巴胺系统的激活(布里斯托等人,1994年)。在本研究中,用L-701,324预处理也逆转了在断奶后饲养于社会隔离环境中的大鼠中观察到的前脉冲抑制(PPI)缺陷。鉴于精神分裂症患者的PPI也会减弱,并且隔离饲养会诱发神经化学和行为异常,提示存在生理诱导的多巴胺能亢进状态,这些结果表明,阻断甘氨酸/N-甲基-D-天冬氨酸受体可能为新型抗精神病药物的开发提供一种新策略。